2004 research showed that CCSK patients exhibit an improved relapse-free survival from a longer course of therapy when using vincristine, doxorubicin, and dactinomycin, but their long-term survival is unchanged compared with patients receiving 6 months of therapy.
Clear-cell sarcoma of the kidney
Renal anaplastic sarcoma
Renal medullary fibroma
Renal medullary carcinoma
Renal oncocytoma
Papillary renal cell carcinoma
Multilocular cystic renal cell carcinoma
Clear cell papillary renal cell carcinoma